发明名称 Heterocyclic compounds
摘要 This invention features a compound of formula (I): R<SUB>1 </SUB>is aryl or heteroaryl; each of R<SUB>2 </SUB>and R<SUB>4</SUB>, independently, is H, halogen, CN, alkyl, OR<SUP>a</SUP>, or NR<SUP>a</SUP>R<SUP>b</SUP>; R<SUB>3 </SUB>is H, halogen, CN, alkyl, alkenyl, alkynyl, aryl, heteroaryl, cyclyl, heterocyclyl, OR<SUP>a</SUP>, OC(O)R<SUP>a</SUP>, OC(O)NR<SUP>a</SUP>R<SUP>b</SUP>, NR<SUP>a</SUP>R<SUP>b</SUP>, NR<SUP>a</SUP>C(O)R<SUP>b</SUP>, NR<SUP>a</SUP>S(O)R<SUP>b</SUP>, NR<SUP>a</SUP>S(O)<SUB>2</SUB>R<SUP>b</SUP>, NR<SUP>a</SUP>C(O)NR<SUP>b</SUP>R<SUP>c</SUP>, NR<SUP>a</SUP>C(S)NR<SUP>b</SUP>R<SUP>c</SUP>, NR<SUP>a</SUP>C(NR<SUP>b</SUP>)NR<SUP>c</SUP>R<SUP>d</SUP>, NR<SUP>a</SUP>C(O)OR<SUP>b</SUP>, S(O)NR<SUP>a</SUP>R<SUP>b</SUP>, S(O)<SUB>2</SUB>NR<SUP>a</SUP>R<SUP>b</SUP>, S(O)R<SUP>a</SUP>, S(O)<SUB>2</SUB>R<SUP>a</SUP>, C(O)R<SUP>a</SUP>, C(O)OR<SUP>a</SUP>, or C(O)NR<SUP>a</SUP>R<SUP>b</SUP>; R<SUB>5 </SUB>is H or alkyl; n is 0, 1, 2, 3, 4, 5, or 6; A is O, S, S(O), S(O)<SUB>2</SUB>, or NR<SUP>e</SUP>; B is N or CR<SUP>f</SUP>; X is O, S, S(O), S(O)<SUB>2</SUB>, NR<SUP>e</SUP>, or C(O); Y is a covalent bond, C(O), C-NR<SUP>a</SUP>, O, S, S(O), S(O)<SUB>2</SUB>, or NR<SUP>e</SUP>; Z is N or CH; each of U and V, independently, is N or CR; and W is O, S, or NR<SUP>e</SUP>; in which each of R<SUP>a</SUP>, R<SUP>b</SUP>, R<SUP>c</SUP>, and R<SUP>d</SUP>, independently, is H, alkyl, aryl, heteroaryl, cyclyl, or heterocyclyl; R<SUP>e </SUP>is H, alkyl, aryl, acyl, or sufonyl; and R<SUP>f </SUP>is H, alkyl, aryl, acyl, sulfonyl, alkoxyl, amino, ester, amide, CN, or halogen. The compound is useful for treating an interleukin-12 overproduction-related disorder.
申请公布号 US7122665(B2) 申请公布日期 2006.10.17
申请号 US20030686505 申请日期 2003.10.14
申请人 SYNTA PHARMACEUTICALS CORP. 发明人 SUN LIJUN;ONO MITSUNORI;WADA YUMIKO;YING WEIWEN;PRZEWLOKA TERESA;KOSTIK ELENA
分类号 C07D413/14;A61P1/00;A61P3/10;A61P17/06;A61P19/02;C07D413/04;C07D473/16;C07D473/18;C07D473/34;C07D487/02 主分类号 C07D413/14
代理机构 代理人
主权项
地址